Page last updated: 2024-08-25

methotrexate and Hand-Foot Syndrome

methotrexate has been researched along with Hand-Foot Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Marin Piñero, D; Perandones González, H; Rusiñol Batlle, L; Vicente Villa, MA1
Bishnu, A; Chauhan, P; Gupta, A; Kumar, S; Nityanand, S1
Baker, SD; Bishop, MW; Cheng, C; Jeha, S; Karol, SE; Pappo, AS; Pui, CH; Relling, MV; Rubnitz, JE; Sandlund, JT; Smith, C; Stewart, CF; Yang, W1
Dührsen, U; Khandanpour, C; Röth, A1
Camilleri, MJ; Podjasek, JO1
Bielack, S; Reeh, T; Wilhelm, M; Zils, K1

Trials

1 trial(s) available for methotrexate and Hand-Foot Syndrome

ArticleYear
Bullous acral erythema: an additional consideration in the differential diagnosis of pauci-inflammatory subepidermal bullae*.
    Journal of cutaneous pathology, 2012, Volume: 39, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blister; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hand-Foot Syndrome; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Prednisolone; Vincristine

2012

Other Studies

5 other study(ies) available for methotrexate and Hand-Foot Syndrome

ArticleYear
Methylprednisolone premedication for prophylaxis of methotrexate-induced acral erythema.
    International journal of dermatology, 2023, Volume: 62, Issue:4

    Topics: Antimetabolites, Antineoplastic; Erythema; Hand-Foot Syndrome; Humans; Methotrexate; Methylprednisolone

2023
Palmar-plantar erythrodysesthesia associated with high-dose methotrexate: Case report.
    Cancer reports (Hoboken, N.J.), 2020, Volume: 3, Issue:5

    Topics: Adult; Burkitt Lymphoma; Dose-Response Relationship, Drug; Hand-Foot Syndrome; Humans; Infusions, Intravenous; Male; Methotrexate; Severity of Illness Index

2020
Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabine.
    Cancer, 2017, Sep-15, Volume: 123, Issue:18

    Topics: Adolescent; Age Distribution; Analysis of Variance; Child; Child, Preschool; Cytarabine; Databases, Factual; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hand-Foot Syndrome; Hematologic Neoplasms; Humans; Incidence; Infusions, Intravenous; Male; Methotrexate; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Distribution

2017
Hand-foot syndrome: common presentation in an uncommon situation.
    European journal of haematology, 2013, Volume: 91, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Hand-Foot Syndrome; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Steroids; Uridine; Vincristine

2013
Bullous variant of acral erythema in a child after high-dose methotrexate.
    Pediatric hematology and oncology, 2012, Volume: 29, Issue:4

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Hand-Foot Syndrome; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma; Vitamin B Complex

2012